LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis GBX 169.60 +4.60 (+2.79%) (As of 12:37 PM ET) Add Compare Share Share Today's Range 164.77▼ 17350-Day Range 163▼ 21552-Week Range 139▼ 238.50Volume859,184 shsAverage Volume389,003 shsMarket Capitalization£405.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get PureTech Health alerts: Email Address Ad Chaikin Analytics50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And in the aftermath of the biggest tech selloff since 2022... He just gave them an urgent SELL alert for one beloved AI stock.To hear the name and ticker of this doomed AI stock, 100% free, click here. About PureTech Health Stock (LON:PRTC)PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesAugust 21, 2024 | americanbankingnews.comPureTech Health (LON:PRTC) Stock Price Crosses Below Fifty Day Moving Average of $183.43April 9, 2024 | markets.businessinsider.comPureTech Names Bharatt Chowrira CEO As Daphne Zohar Turns CEO Of Newly Launched Seaport TherapeuticsAugust 28, 2024 | Chaikin Analytics (Ad)50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And in the aftermath of the biggest tech selloff since 2022... He just gave them an urgent SELL alert for one beloved AI stock.April 2, 2024 | msn.comHere’s one FTSE 250 stock I’d buy in AprilMarch 22, 2024 | thestreet.comPureTech Health plcMarch 19, 2024 | msn.comPureTech announces $100M capital return through tender offerFebruary 28, 2024 | finance.yahoo.comAKLI Mar 2024 1.000 callFebruary 8, 2024 | msn.com2 impressive growth stocks I’ve got my eye on in FebruaryAugust 28, 2024 | Chaikin Analytics (Ad)50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And in the aftermath of the biggest tech selloff since 2022... He just gave them an urgent SELL alert for one beloved AI stock.November 17, 2023 | finance.yahoo.comPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNovember 14, 2023 | lse.co.ukPureTech Health celebrates positive results in Phase 2 anxiety trialNovember 14, 2023 | finance.yahoo.comPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersAugust 29, 2023 | finanznachrichten.dePureTech Health plc - Half-Year ReportAugust 1, 2023 | msn.comPureTech bags $11.4M from U.S. Department of Defense contractAugust 1, 2023 | finance.yahoo.comPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia SyndromeJune 21, 2023 | lse.co.ukPureTech Health launches next stage of anxiety disorder drug trialJune 21, 2023 | finance.yahoo.comPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety DisordersApril 29, 2023 | benzinga.comPureTech Health Stock (NASDAQ:PRTC), DividendsSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CUSIPN/A CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-65,700,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-13.25% Return on Assets-13.09% Debt Debt-to-Equity Ratio29.57 Current Ratio6.76 Quick Ratio2.51 Sales & Book Value Annual Sales£3.33 million Price / Sales121.89 Cash FlowGBX 79.19 per share Price / Cash Flow2.14 Book ValueGBX 171 per share Price / Book0.99Miscellaneous Outstanding Shares239,320,000Free FloatN/AMarket Cap£405.89 million OptionableNot Optionable Beta1.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMs. Daphne Zohar (Age 47)Founder, CEO & Exec. Director Dr. Bennett M. Shapiro (Age 78)Co-Founder & Non-Exec. Director Dr. Robert S. Langer Jr. (Age 69)Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board Mr. Stephen M. Muniz J.D. (Age 48)COO, Exec. VP of Legal & Operations, Sec. and Exec. Director Dr. Bharatt M. Chowrira (Age 53)Pres and Chief of Bus. & Strategy Key CompetitorsGenusLON:GNSOxford Nanopore TechnologiesLON:ONTErgomedLON:ERGOSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBView All CompetitorsInsidersRobert LangerSold 233,098 sharesTotal: £58.27 M ($250.00/share)View All Insider Transactions PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed this year? PureTech Health's stock was trading at GBX 194.20 on January 1st, 2024. Since then, PRTC stock has decreased by 12.7% and is now trading at GBX 169.60. View the best growth stocks for 2024 here. How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), Boeing (BA), Baozun (BZUN) and Chaarat Gold (CGH). This page (LON:PRTC) was last updated on 8/28/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressHow likely is a Trump victory? Polymarket (the world's largest prediction market) gives Trump a 63% chance ...Colonial Metals | Sponsored50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly ...Chaikin Analytics | SponsoredFirst Disruption to $martphones in 15 Years 🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredThese 3 Tech Billionaires Are Prepared for a Radical New Money System. Are You?Ultra-Capitalism is Coming A revolutionary new technological breakthrough is about to ignite a new era of w...Banyan Hill Publishing | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.